MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2174/1871530323666230911140635

Медицинская библиотека · Endocrine, metabolic & immune disorders drug targets · 2024

Association of Obesity based on Different Metabolic Status with Risk of Gout Occurrence in Patients: A National Study.

Wang Yanyan, Liu Luna, Ma Shizhan, Han Junming, Wang Zhixiang, Fan Xiude, Hou Xu

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Obesity often co-exists with metabolic abnormalities, but the results of studies on the relationship between obesity, metabolic abnormalities and the risk of gout are inconsistent.

OBJECTIVES

We aimed to study whether there was a mutual regulation between obesity, metabolic abnormalities and the risk of gout.

METHODS

We conducted a cross-sectional study to expound the association between obesity based on different metabolic statuses and the risk of gout. Patients were derived from Nationwide Readmission Database (2018 sample).

RESULTS

A total of 9,668,330 records were recruited for analysis from January to December. The risk of gout in the obesity group, metabolic abnormalities group and obesity combined with metabolic abnormalities group was 1.67 times (OR = 1.67, 95%CI 1.64-1.70), 3.12 times (OR = 3.12, 95%CI 3.09-3.15) and 4.27 times (OR = 4.27, 95%CI 4.22-4.32) higher than that in the normal control group. For different metabolic components, OR value was highest in hypertension group (OR = 2.65, 95%CI 2.60-2.70 and OR = 4.85, 95%CI 4.73-4.97), followed by dyslipidemia group (OR = 2.23, 95%CI 2.16-2.30 and OR = 3.74, 95%CI 3.55-3.95) and in hyperglycemia group (OR = 1.73, 95%CI 1.66-1.80 and OR = 2.94, 95%CI 2.78-3.11). Fewer components of metabolic syndrome were associated with a lower risk of gout in both nonobese and obese patients.

CONCLUSION

When metabolic abnormalities were present, obesity induced a higher risk of gout. Different components of metabolic abnormalities had different effects on the risk of gout occurrence, and the number of metabolic abnormalities was closely related to the risk of gout occurrence. Follow-up and intervention methods targeting obesity and metabolic abnormalities should be considered for patients with gout.

Для цитирования: Wang Yanyan, Liu Luna, Ma Shizhan, Han Junming, Wang Zhixiang, Fan Xiude, Hou Xu. Association of Obesity based on Different Metabolic Status with Risk of Gout Occurrence in Patients: A National Study.. Endocrine, metabolic & immune disorders drug targets. 2024. DOI: 10.2174/1871530323666230911140635.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.